Table 1 Baseline characteristics of patients with T2DM and without history of CVD, CKD, and cancer at the time of T2DM diagnosis, by mortality status

Patients, number (%)^a

136,832 (94)

8226 (6)

145,058 (100)

Age in years, mean (SD)^b

51 (12)

60 (9)

52 (12)

  Age group ^a

   ≤40 years

25,693 (19)

304 (4)

25,997 (18)

   41–50 years

33,313 (24)

824 (10)

34,137 (24)

   51–60 years

43,069 (32)

2420 (29)

45,489 (31)

   61–70 years

34,757 (26)

4678 (57)

39,435 (27)

Male^a

76,054 (56)

4890 (60)

80,944 (56)

Smoking status^a

  Current smoker

28,875 (21)

2385 (29)

31,260 (22)

  Ex-smoker

40,821 (30)

2805 (34)

43,626 (30)

  Never smoked

66,182 (48)

2823 (34)

69,005 (48)

Townsend deprivation^a

  Least deprived

21,542 (16)

1443 (18)

22,985 (16)

  Most deprived

26,678 (20)

1400 (17)

28,078 (19)

Body weight in kg, mean (SD)^b

93.4 (19.3)

90.4 (19.1)

93.2 (19.3)

BMI (kg/m²)^b, mean (SD)

32.7 (6.3)

31.8 (6.4)

32.7 (6.3)

BMI categories^a

  Underweight

208 (<0.1)

52 (1)

260 (<0.1)

  Normal weight

9770 (7)

764 (9)

10,534 (7)

  Overweight

36,404 (27)

2444 (30)

38,848 (27)

  Grade 1 Obese

52,400 (39)

3159 (38)

55,559 (39)

  Grade 2 Obese

22,790 (17)

1054 (13)

23,844 (16)

  Grade 3 Obese

15,260 (11)

753 (9)

16,013 (11)

SBP (mm/Hg)^b

139 (17)

144 (18)

140 (17)

SBP ≥ 140^a

64,881 (47)

4973 (60)

69,854 (48)

HbA_1c (mmol/mol^b)

69 (18.6)

68 (17.5)

69 (18.6)

HbA_1c ≥ 58 (mmol/mol^a)

96,567 (70)

5956 (72)

102,523 (71)

LDL-C (mmol/L^b)

3.26 (0.75)

3.15 (0.67)

3.23(0.75)

HDL-C (mmol/L^b)

1.16 (0.28)

1.21 (0.31)

1.16(0.28)

Triglycerides (mmol/L^c)

1.90 (1.50, 2.36)

1.87 (1.5, 2.29)

1.90 (1.50, 2.35)

Follow-up (years)^c

7 (4, 11)

11 (8, 13)

8 (4, 11)